Cancer is the second leading cause of death globally, according to the World Health Organization. Prevention and early screening are crucial elements of interprofessional strategies to reduce the burden, morbidity and mortality associated with cancer, as are medication management for optimal outcomes, and patient support. Pharmacists have a key role to play in all these areas. At this digital event, FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in cancer which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.

Attendees will learn about:

1. The role of pharmacists in the prevention, screening, care and management of cancer;
2. Challenges and opportunities for pharmacists in implementing cancer-related services;
3. The knowledge and skills pharmacists need to acquire to support their role in the delivery of cancer-related services.

Moderator:

-Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, Portugal

Panelists:
-Evelyn Handel, ISOPP President (2022-2024) International Society of Oncology Pharmacy Practitioners (ISOPP), USA
-Folakemi T. Odedina, Professor of Oncology Mayo Clinic Cancer Center, USA
-Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Canada
-Dalia Bajis, Lead for provision and partnerships FIP, Australia

This webinar is the second of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover:
- Ongoing technological developments, including:
o Multi-omics
o Single-cell sequencing
o High-resolution imaging
o Combinatorial drug screens
o Biostatistics, machine learning and open software repositories
- Examples of clinical translation of the above technologies in a research context
- Thoughts on future directions of the field, and unaddressed gaps.

At the end of this session, participants will:
1. Have an awareness of some of the key technological advances driving the evolution of precision medicine.
2. Be familiar with some examples of its potential implementation
3. Be aware of current limitations and remaining challenges to be addressed


Co-Chairs:
-Donnacha Fitzgerald, FIP Technology Forum member, Predoctoral Fellow The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital, Germany
-R. Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA

Panellists:
-Wolfgang Huber, Co-Director, Molecular Medicine Partnership Unit Group Leader ad Senior Scientist The European Molecular Biology Laboratory (EMBL), Germany
-Christoph Merten, Associate Professor Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland

The COVID19 pandemic has highlighted that we need better antiviral therapies, especially for respiratory viral diseases. We have developed inhalation therapies consisting of siRNA nanoparticles which inhibit the viral genome of coronaviruses. The advantage over vaccination is the therapeutic index for virus variants and new coronaviruses. Other so far undruggable targets are transcription factors which are often drivers of tumorigenesis. Accordingly, examples for pulmonary delivery of therapeutic RNA in asthma, targeting GATA-3, and in lung cancer, targeting mutated KRAS, will be discussed.

Learning objectives:
*siRNA nanoparticles for inhalation delivery
*Application to un- druggable targets like transcription factors

Moderator:
Mathew Cherian, ExCo Member, Industrial Pharmacy Section, Consultant-USA

Co-moderator:
Kaushik Desai, Associate ExCo Member, Industrial Pharmacy Section, Secretary General International Pharmaceutical Excipients’ Council of India-India

Panelist:
Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU) Munich, Germany

In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by  working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here. 

In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by  working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here. 

The World Health Organization estimate that 17.9 million people die from cardiovascular diseases each year, representing 32% of all global deaths. Pharmacists have a role to play in the prevention, care and management of cardiovascular diseases and their complications. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cardiovascular diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.

Learning objectives:

1. Explore the role of pharmacists in the prevention, care and management of cardiovascular diseases and their complications;
2. Identify the challenges and opportunities for pharmacists in addressing cardiovascular diseases;
3. Identify the relevant knowledge and skills required for the delivery of cardiovascular diseases-related services.

Current and future pharmaceutical education. Enablers and barriers to innovation and high quality education.

Among the greatest bottlenecks for the widespread implementation of precision medicine is the growing costs of the associated technologies. It also brings new challenges for health technology assessment, with cost-utility becoming more difficult to evaluate and predict at finer levels of patient stratification. What are these challenges? How could we address them? How might we go about refining precision medicine strategies to maximize cost utility?

The webinar will cover:

- The current health technology assessment stance on precision medicine applications

- What we know and what we don’t know about the cost-utility of new precision medicine approaches against the standard of care

- How costs may evolve with emerging technologies or trends

- Priorities for future health economics research in this area

The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.

By the end of the session participants should be able to:

• Understand the roles pharmacists can play in HIV prevention, screening and management
• Recognise some resources and tools that pharmacists can use in this area
• Find and use the FIP toolkit on HIV prevention, screening and management

Current and future science. Enablers and barriers to innovation and collaboration across pharmaceutical science.